Muventhiran Ruthranesan. (2009). Response rate and progression-free survival in locally advanced or metastatic primary lung adenocarcinoma treated with gefitinib.
Chicago Style (17th ed.) CitationMuventhiran Ruthranesan. Response Rate and Progression-free Survival in Locally Advanced or Metastatic Primary Lung Adenocarcinoma Treated with Gefitinib. 2009.
MLA引文Muventhiran Ruthranesan. Response Rate and Progression-free Survival in Locally Advanced or Metastatic Primary Lung Adenocarcinoma Treated with Gefitinib. 2009.
警告：這些引文格式不一定是100％准確.